BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribaldone DG, Pellicano R, Actis GC. Inflammation: a highly conserved, Janus-like phenomenon—a gastroenterologist’ perspective. J Mol Med 2018;96:861-71. [DOI: 10.1007/s00109-018-1668-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Zhong F, Zheng X, Lai H, Wu C, Huang C. Disparity of Gut Microbiota Composition Among Elite Athletes and Young Adults With Different Physical Activity Independent of Dietary Status: A Matching Study. Front Nutr 2022;9:843076. [DOI: 10.3389/fnut.2022.843076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gradisteanu Pircalabioru G, Ilie I, Oprea L, Picu A, Petcu LM, Burlibasa L, Chifiriuc M, Musat M. Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome—A Pilot Study. Metabolites 2022;12:218. [DOI: 10.3390/metabo12030218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Actis GC, Ribaldone DG, Pellicano R. COVID vaccine's hot problems: erratic serious blood clotting, ill-defined prion-like reactogenicity of the spike, unclear roles of other factors. Minerva Med 2021;112:695-7. [PMID: 35168305 DOI: 10.23736/S0026-4806.21.07769-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Abiega-Franyutti P, Freyre-Fonseca V. Chronic consumption of food-additives lead to changes via microbiota gut-brain axis. Toxicology 2021;464:153001. [PMID: 34710536 DOI: 10.1016/j.tox.2021.153001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Mao L, Zhang Y, Tian J, Sang M, Zhang G, Zhou Y, Wang P. Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China. Front Microbiol 2021;12:728479. [PMID: 34650532 DOI: 10.3389/fmicb.2021.728479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Khumalo GP, Van Wyk BE, Feng Y, Cock IE. A review of the traditional use of southern African medicinal plants for the treatment of inflammation and inflammatory pain. J Ethnopharmacol 2021;:114436. [PMID: 34289396 DOI: 10.1016/j.jep.2021.114436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
7 Luthra-Guptasarma M, Guptasarma P. Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19? Bioessays 2021;:e2000211. [PMID: 34213801 DOI: 10.1002/bies.202000211] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Castellano F, Alessio G, Palmisano C. Ocular manifestations of inflammatory bowel diseases: an update for gastroenterologists. Minerva Gastroenterol (Torino) 2021;67:91-100. [PMID: 32677418 DOI: 10.23736/S2724-5985.20.02727-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Finucci A, Ditto MC, Parisi S, Borrelli R, Priora M, Realmuto C, Fusaro E. Rheumatic manifestations in inflammatory bowel disease. Minerva Gastroenterol (Torino) 2021;67:79-90. [PMID: 32623869 DOI: 10.23736/S2724-5985.20.02726-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lo Pumo S. A place for probiotics and prebiotics in the studies on human microbiota and inflammatory bowel diseases. Minerva Gastroenterol Dietol 2020;66:82. [PMID: 32283884 DOI: 10.23736/S1121-421X.19.02620-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Qin XR, Wu J, Yao XY, Huang J, Wang XY. Helicobacter pylori DNA promotes cellular proliferation, migration, and invasion of gastric cancer by activating toll-like receptor 9. Saudi J Gastroenterol 2019;25:181-7. [PMID: 30618438 DOI: 10.4103/sjg.SJG_309_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Rizza S, Mistrangelo M, Ribaldone DG, Morino M, Astegiano M, Saracco GM, Pellicano R. Proctitis: a glance beyond inflammatory bowel diseases. Minerva Gastroenterol Dietol 2020;66:252-66. [PMID: 32218425 DOI: 10.23736/S1121-421X.20.02670-7] [Reference Citation Analysis]
13 Ribaldone DG, Procopio M, Pellicano R, Barale M, Giudici G, Morino M, Saracco GM, Astegiano M. Predictors of risk of fracture in inflammatory bowel diseases: a prospective study using FRAX score. Minerva Gastroenterol Dietol 2020;66:106-12. [PMID: 32218426 DOI: 10.23736/S1121-421X.20.02672-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ribaldone DG, Caviglia GP, Abdulle A, Pellicano R, Ditto MC, Morino M, Fusaro E, Saracco GM, Bugianesi E, Astegiano M. Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease. J Clin Med 2019;8:E1646. [PMID: 31601034 DOI: 10.3390/jcm8101646] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 8.7] [Reference Citation Analysis]
15 Pellicano R. Human microbiota and inflammatory bowel diseases: new pieces of an intricate puzzle. Minerva Gastroenterol Dietol 2019;65:171-2. [PMID: 31602969 DOI: 10.23736/S1121-421X.19.02616-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Vernero M, Boano V, Ribaldone DG, Pellicano R, Astegiano M. Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.19.02572-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
17 Vernero M. Is urotensin II a new inflammatory marker of inflammatory bowel disease? Minerva Gastroenterol Dietol 2019;65:173-4. [PMID: 31347342 DOI: 10.23736/S1121-421X.19.02611-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ribaldone DG, Pellicano R, Actis GC. Inflammation in gastrointestinal disorders: prevalent socioeconomic factors. Clin Exp Gastroenterol 2019;12:321-9. [PMID: 31410046 DOI: 10.2147/CEG.S210844] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
19 Masoodi I, Alshanqeeti AS, Ahmad S, Alyamani EJ, Al-Lehibi AA, Qutub AN, Alsayari KN, Alomair AO. Microbial dysbiosis in inflammatory bowel diseases: results of a metagenomic study in Saudi Arabia. Minerva Gastroenterol Dietol 2019;65:177-86. [PMID: 31293117 DOI: 10.23736/S1121-421X.19.02576-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
20 Korotkyi OH, Vovk AA, Dranitsina AS, Falalyeyeva TM, Dvorshchenko KO, Fagoonee S, Ostapchenko LI. The influence of probiotic diet and chondroitin sulfate administration on Ptgs2, Tgfb1 and Col2a1 expression in rat knee cartilage during monoiodoacetate-induced osteoarthritis. Minerva Med 2019;110. [DOI: 10.23736/s0026-4806.19.06063-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
21 Armandi A, Bonetto S, Pellicano R, Caviglia GP, Astegiano M, Saracco GM, Ribaldone DG. Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02556-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Korotkyi O, Vovk A, Galenova T, Vovk T, Dvorschenko K, Luzza F, Abenavoli L, Kobyliak N, Falalyeyeva T, Ostapchenko L. Effect of probiotic on serum cytokines and matrix metalloproteinases profiles during monoiodoacetate-induced osteoarthritis in rats. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02548-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
23 Ribaldone DG, Pellicano R, Actis GC. The gut and the inflammatory bowel diseases inside-out: extra-intestinal manifestations. Minerva Gastroenterol Dietol 2019;65:309-18. [PMID: 30994321 DOI: 10.23736/S1121-421X.19.02577-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
24 Actis GC. Helicobacter pylori infection and Parkinson's disease. Minerva Gastroenterol Dietol 2019;65:164-5. [PMID: 30746924 DOI: 10.23736/S1121-421X.19.02554-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Connors J, Dawe N, Van Limbergen J. The Role of Succinate in the Regulation of Intestinal Inflammation. Nutrients 2018;11:E25. [PMID: 30583500 DOI: 10.3390/nu11010025] [Cited by in Crossref: 59] [Cited by in F6Publishing: 76] [Article Influence: 14.8] [Reference Citation Analysis]
26 Mosso E, Boano V, Grassini M, Battaglia E, Pellicano R. Microscopic colitis: a narrative review with clinical approach. Minerva Gastroenterol Dietol 2019;65:53-62. [PMID: 30486642 DOI: 10.23736/S1121-421X.18.02539-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Ribaldone D, Pellicano R, Actis G. Pathogenesis of Inflammatory Bowel Disease: Basic Science in the Light of Real-World Epidemiology. GastrointestDisord 2018;1:129-46. [DOI: 10.3390/gidisord1010010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]